From the Contents: ABC Transporters -- Absorption -- Abstinence -- Abuse -- Abuse Liability -- Acamprosate -- BAC -- Balanced Placebo Design -- Barbital -- Barbiturates -- Basal Forebrain Cholinergic Neurons -- Behavioral Allocation Function -- Cabergoline -- Cachexia -- Caffeine -- Caffeine Withdrawal Syndrome -- Caffeinism -- cAMP -- DARPP-32 -- db/db Mouse -- D-cycloserine -- Decision Making -- Declarative and Non-Declarative Memory -- Declarative Memory -- Early Ventral Hippocampal Lesion Model -- Eating and Appetite -- Eating Disorder: Anorexia Nervosa -- Eating Disorders: Animal Models -- Eating Disorders: Binge-Eating -- Echolalia -- FAA -- Face Validity -- Facial Dysmorphology -- False Memory -- False Negative -- False Positive -- G protein-Coupled Receptors -- GABA -- GABAA Receptor -- GABAergic Transmission -- Gabapentin -- Galantamine -- Habit Reversal Therapy -- Habit Reversal Training -- Habituation -- Half-Life -- Hallucinations -- Hallucinogen Abuse -- IACUC -- ICD -- Idiopathic -- Imaging Mass Spectrometry -- Imipramine -- Impairment of Functioning; Measurement Scales -- Kappa-Opioid Agonists -- Kappa-Receptor -- Keratotic Lesion -- Ketamine -- Ketamine -- Khat -- L-Alpha-Acetyl-Methadol -- Lamotrigine -- Lanreotide -- Latent Inhibition -- Latin Square Design -- Laxatives -- Magnetic Resonance Imaging -- Major and Minor and Mixed Anxiety-Depressive Disorders -- Major Tranquilizer -- Mania -- MAO-B Inhibitor -- Mass Spectrometry -- N-Acetylcysteine -- Nafion -- Naloxone -- Naltrexone -- N-Arachidonylethanolamine -- Narcolepsy -- ob/ob Mouse -- Obsessions -- Obsessive-Compulsive Anxiety Disorders -- Occasion Setting with Drugs -- Octreotide -- Off-Label Use of Drugs -- P300 -- Pain -- Pain and Psychopharmacology -- Pair-Feeding -- Palatability -- Paliperidone -- qEEG -- QT Interval -- Quality of Life -- Quazepam -- Quetiapine -- Radial Arm Maze -- Radionuclide -- Radiopharmaceutical -- Radiotracer -- Randomized Controlled Trials -- Rapamycin -- Saporin -- Satiety -- Saturation Binding Curve -- Scalar Property -- Schedule I -- Schedule II -- Tachykinins.-Tachyphylaxis -- Tandospirone -- Tardive Dyskinesia -- Taste Reactivity Test -- Temazepam -- Ubiquitin-Proteasome System -- Ultrasonic -- Ultrasonic Vocalizations -- Ultrasonic Vocalizations -- Unblocking -- Unconditional Response -- Vaccination -- Vaccines and Drug-Specific Antibodies -- Vagus Nerve Stimulation -- Valproic Acid -- Values-Based Medicine -- Varenicline -- Wakefulness -- Water Maze -- Whole-Cell Recording -- Wisconsin Card Sorting Test -- Wisconsin General Test Apparatus -- Withdrawal Syndromes -- Yale-Brown Obsessive-Compulsive Scale -- Yohimbine -- Zaleplon -- Zero-Order Elimination Kinetics -- Ziprasidone -- Zolpidem -- Zonisamide -- Zopiclone.